Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
10/23/2018
LSK and Jiangsu Hengrui Announce Global Clinical Collaboration for HCC
10/23/2018
China Is Funding the Future of American Biotech
10/23/2018
China Electronics Data and WuXi AppTec Form Healthcare Big Data JV
10/23/2018
Huahai Pharma Faces Lawsuits on Cancer-Causing Valsartan in the U.S.
10/23/2018
Sanofi Taps Government Program for Entry into Chinese Primary Healthca...
10/22/2018
Zai Lab Announces Approval of Niraparib for Relapsed Ovarian Cancer in...
10/22/2018
Reistone Biopharma to Initiate Its Ulcerative Colitis Phase II Trial G...
10/18/2018
Chi-Med Starts Phase I Study of HMPL-523 for Leukemia In China
10/18/2018
Recent Executive Moves
10/18/2018
IQVIA: Chinese Hospital Drug Market Up 2.8% in MAT Q2/2018
10/18/2018
NHC Drafts Plan to Boost Overall Clinical Appraisal of Drug Products
10/18/2018
Novo Nordisk to Restructure and Launch 10 New Drugs in China by 2026
10/17/2018
China's Pharmaceutical Firms Feel First Impact From Trump's Trade War
10/17/2018
CDE Publicizes Batch 33 of Drug Applications To Be Granted Priority Re...
10/17/2018
Eisai's NDA for Antiepileptic Perampanel Accepted in China
10/16/2018
DiaMedica and Fosun Subsidiary Signs License Agreement for Stroke Medi...
10/16/2018
Alphamab's HER2 Bispecific Antibody KN026 Gains US IND
10/16/2018
CStone Receives U.S. IND Approval for PD-L1 Antibody CS1001
10/16/2018
Targeting the Affluent: Differential Access to Targeted Therapies in C...
10/16/2018
Changchun Changsheng Biotech Fined CNY 9.1B in Vaccine Scandal
10/15/2018
How to Fulfill China’s Potential for Carrying Out Clinical Trials
10/15/2018
Innovent Granted Chinese IND for Sintilimab/Bevacizumab Combinaiton Th...
10/15/2018
Zheijiang Huahai Placed under Increased Supervision
10/15/2018
Exploring Ways to Establish Presence in China as Part of APAC Region P...
10/15/2018
NHC Outlines Drug Administrative Policy Directions and Tasks in Nation...
10/12/2018
Eisai's NDA for Antiepileptic Drug Perampanel Accepted in China
10/12/2018
Mesoblast and Tasly Complete Strategic Cardiovascular Partnership in C...
10/11/2018
NEJM and CCA Enter Partnership for CVS Research and Training
10/11/2018
MEI Pharma and BeiGene Announce Collaboration for ME-401/Zanubrutinib ...
10/11/2018
State Council Issues New Document to Reform Licensing Mechanisms
Page:
329
/
797
Total number of articles:
23898
:
[First]
[<<]
[327]
[328]
[329]
[330]
[331]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit